This study tested the hypothesis that bromate (KBrO 3 )-induced renal cell death is mediated by epigenetic mechanisms. Global DNA methylation, as assessed by 5-methylcytosine staining, was not changed in normal rat kidney cells treated with acute cytotoxic doses of KBrO 3 (100 and 200 ppm), as compared with controls. However, KBrO 3 treatment did increase p38, p53 and histone 2AX (H2AX) phosphorylation, and p21 expression. Treatment of cells with inhibitors of DNA methyltransferase (5-azacytidine or 5-Aza) and histone deacetylase (trichostatin A or TSA) in addition to KBrO 3 increased cytotoxicity, as compared with cells exposed to KBrO 3 alone. 5-Aza and TSA co-treatment did not alter p38 or p53 phosphorylation, but slightly decreased H2AX phosphorylation and significantly decreased p21 expression. We also assessed epigenetic changes in cells treated under sub-chronic conditions with environmentally relevant concentrations of KBrO 3 . Under these conditions (0-10ppm KBrO 3 for up to 18 days), we detected no increases in cell death or DNA damage. In contrast, slight alterations were detected in the phosphorylation of H2AX, p38, and p53. Sub-chronic low-dose KBrO 3 treatment also induced a biphasic response in p21 expression, with lower concentrations increasing expression, but higher concentrations decreasing expression. Methylation-specific PCR demonstrated that sub-chronic KBrO 3 treatment altered the methylation of cytosine bases in the p21 gene, as compared with controls, correlating to alterations in p21 protein expression. Collectively, these data show the novel finding that KBrO 3 -induced renal cell death is altered by inhibitors of epigenetic modifying enzymes and that KBrO 3 itself induces epigenetic changes in the p21 gene.
ABBREVIATIONS
Potassium bromate NRK Normal rat kidney TSA Trichostatin A Chlorination, ozonation, or the use of ultraviolet light on public water protects an estimated 260 million Americans from waterborne pathogens that would otherwise be present in drinking, cooking, or bathing water. Unfortunately, these processes also oxidize organic and inert elements into disinfection byproducts (DBPs). Some of these DBPs are known to cause risks to human health (Richardson et al., 2007) . For example, exposure to high levels of select DBPs can cause cancer in rodents (Bull and Cottruvo, 2006; Umemura et al., 2006; Wolf et al., 1998) , as well as increases in miscarriages and the onset of select cancers in humans (Sedlak and von Gunten, 2011) . Bromate (BrO 3 − ) is a DBP formed after the ozonation of water and the oxidation of bromide (Br − ), an anthropogeneic contaminant that naturally exists in ground water (von Gunten and Hoigne, 1994) . KBrO 3 is known to induce renal cancers in male C The Author 2014. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For permissions, please email: journals.permissions@oup.com and female rats, as well as thyroid cancer and testicular cancer in male rats Kurokawa et al., 1990; Wolf et al., 1998) . Studies assessing the tumorigenic effect of high levels of KBrO 3 showed that renal neoplasias correlated to the induction of 8-hydroxyguanosine (8-OHdG), a mutagenic oxidative DNA lesion (Kasai et al., 1987) . However, subsequent studies showed that knocking out 8-OHdG glycosylase activity did not increase renal neoplasia in comparison with wild-type liter mates, despite a large increase in 8-OHdG adducts (Arai et al., 2002) . This observation indicates that KBrO 3 genotoxicity does not correlate with tumor susceptibility, suggesting that other mechanisms may mediate its nephrotoxicity and/or carcinogenesis. Given the ability of KBrO 3 to alter DNA, we hypothesized that this DBP may also induce epigenetic changes and that such changes may mediate KBrO 3 -induced nephrotoxicity. Our lab previously reported on the non-epigenetic mechanisms of KBrO 3 nephrotoxicity using both in vitro and in vivo models (Kolisetty et al., 2013a (Kolisetty et al., , 2013b Zhang et al., 2010 Zhang et al., , 2011 . Our studies suggested that KBrO 3 -induced nephrotoxicity was mediated by oxidative stress-and DNA damage-dependent mechanisms. Our in vitro studies showed that KBrO 3 treatment induced the expression of the tumor suppressor protein p53 and the cyclin-dependent kinase inhibitor p21 (Zhang et al., 2010) . Our in vivo studies showed that KBrO 3 treatment increased p21 expression in the proximal tubule region of the rat kidney (Kolisetty et al., 2013a (Kolisetty et al., , 2013c .
p21, also known as cyclin-dependent kinase inhibitor 1a (Cdkn1a), is a critical signaling protein that mediates several cellular processes including cell cycle, cell death and senescence (Jung et al., 2010; Price et al., 2009) . Activation of p21 typically protects against numerous nephrotoxic events (Jiang and Dong, 2008; Megyesi et al., 2001; Nowak et al., 2003; Price et al., 2009) ; however, p21 has also been hypothesized to be a driver of carcinogenesis via its ability to inhibit apoptosis and facilitate DNA repair (Abbas and Dutta, 2009; Gartel, 2009) . Although studies have shown that p21 is regulated via epigenetic pathways (Jung et al., 2010; Yoon et al., 2012) , the ability of KBrO 3 , or any other DBP, to epigenetically alter p21 expression has never been reported.
DNA methylation is one epigenetic event that can alter gene expression, protein expression, and cell function (Phillips, 2008) . Essentially, it is the covalent addition of a methyl group, catalyzed by DNA methyltransferase (DNMT), to the 5-carbon of a cytosine residue in a CpG dinucleotide (Jaenisch and Bird, 2003) . This methyl group impedes the binding of transcription proteins, silencing a gene's transcription (Yu and Wang, 2008) . A number of tumor suppressor genes are silenced by methylation, including several cell cycle regulatory genes, p14, p15, p16, p57kip2, and Rb (Mathews et al., 2009) .
Another type of epigenetic event is histone modification. Eukaryotic DNA is wrapped around histone octamers, which consist of four different histones: H2A, H2B, H3, and H4 (Luger et al., 1997) . The N-terminal tail of each histone can be posttranscriptionally modified by lysine acetylation, lysine and arginine methylation, serine and threonine phosphorylation, and lysine ubiquitination and sumoylation (Vaquero et al., 2003) . Promoter-specific histone modifications can result in improper silencing or transcription of a gene, which can lead to cellular transformation, carcinogenesis, or cancer progression (Fraga et al., 2005; Shiio and Eisenman, 2003) . Generally, histone acetylation induces gene activation by decreasing the histone's affinity for DNA, resulting in a more open conformation, referred to as euchromatin. Conversely, loss of an acetyl group, catalyzed by histone deacetylase (HDAC), results in the formation of heterochromatin and gene silencing. Similar to DNA methylation, it is not known if histone acetylation can mediate KBrO 3 toxicity.
This study tested the hypothesis that KBrO 3 -induced renal cell death is mediated by epigenetic pathways. To test this hypothesis, we determined the effect of inhibitors of both DNA methylation and histone deacetylation on the nephrotoxicity of KBrO 3 in vitro. Additionally, we determined the ability of these inhibitors to alter KBrO 3 -induced changes in the expression of stress-related proteins such as p38, p53, and especially p21. Finally, we assessed the ability of KBrO 3 to induce DNA methylation of p21.
MATERIALS AND METHODS

Materials.
Normal rat kidney (NRK) and human embryonic kidney (HEK293) cells, Dulbecco's Modified Eagle Medium (DMEM) media, F-12K media, and fetal bovine serum were purchased from American Type Culture Collection (Mannasas, VA). Antibiotic antimycotic solution was purchased from Sigma-Aldrich (St. Louis, MO). Potassium bromate (KBrO 3 ), 5-azacytidine (5-Aza), trichostatin A (TSA), and 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) were purchased from Sigma-Aldrich. KBrO 3 was dissolved in deionized water and all other chemicals were dissolved in dimethyl sulfoxide (DMSO) from Fisher Scientific (Pittsburg, PA). Mouse anti-human p21 and phospho-histone 2AX (H2AX) antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Rabbit anti-rat phospho-p38, phospho-p53, and p38 antibodies were purchased from Cell Signaling Technology (Danvers, MA). Secondary antibodies were obtained from Promega (Madison, WI). According to the manufacturer's notes, most of these antibodies cross-react with both rat and human tissues, and we verified the crossreactivity of several of these antibodies prior to this study.
MTT assay. The staining of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) was used as an indicator of toxicity and corroborated with phase contrast microscopy. All cells were seeded in 48-well plates at 100,000 cells/ml and were grown for 48 h. After this time, cells were treated with varying concentrations of epigenetic inhibitors (5-Aza, TSA) or vehicle control in the presence or absence of KBrO 3 for 48 h, and never above 1% of the total volume per well. After 48 h, 0.25 mg/ml of MTT was added to each well and the plates were incubated for 2 h. The media was then aspirated and replaced with DMSO. The plates were shaken at 100 rpm for 15 min to dissolve all precipitates and the absorbance of each well, including control and blank wells, was measured at 544 nm with a FLUOstar OPTIMA plate reader (BMG Lab Technologies, Inc., Durham, NC).
Immunoblot analysis. Cells were seeded in 12-well plates at a concentration of 150,000 cells/ml and allowed to grow for 24 h (90% confluent) prior to addition of epigenetic inhibitors and/or KBrO 3 . After treatment, cells were washed three times and removed using a rubber policeman in immunoblot buffer (0.25-M Tris-HCl (pH 6.8), 4% SDS, 10% glycerol, 1-mg/ml bromophenol blue, and 0.5% (v/v) 2-mercaptoethanol). Protein levels were determined in duplicate wells using lysis buffer that contained 1% (v/v) Triton X-100. Cell lysates containing 20-g total protein were heated to 70
• C for 10 min. Protein was separated under reducing conditions on a 12% SDS-polyacrylamide gel and transferred to a nitrocellulose membrane. Non-specific binding was blocked by incubating the membrane with 3% (w/v) bovine serum albumin in TBS buffer (10-mM Tris-HCl, pH 7.5, 150-mM NaCl) overnight at room temperature. Membranes were
FIG. 1.
Effect of KBrO3 on global DNA methylation in NRK cells. Cells were exposed to 100 ppm or 200 ppm KBrO3. After 3 days, cells were fixed for analysis of 5-methylcytosine (FITC) and nuclear morphology (DAPI) using fluorescence microscopy. DAPI staining alone is shown in the left most column (psuedo colored red) and 5-methylcytosine alone is shown in the middle column. Images were merged in the third column. Data are representative of at least three independent experiments (n = 3). then incubated with the indicated primary antibody for 2 h, followed by incubation in the appropriate secondary antibody for 1.5 h. Bands were detected by enhanced chemiluminescence (GE Healthcare, Chalfont St. Giles, UK).
FIG. 2. Effect of epigenetic inhibitors on
Immunofluorescence. Cells (64,000-128,000 cells/ml) were grown on glass coverslips for 24 h and then treated. Following KBrO 3 treatment, cells were fixed using 10% buffered formalin/4% formaldehyde and washed with PBS. Cells were then permeabilized, washed with PBS, and non-specific binding was blocked by incubation in 8% (w/v) bovine serum albumin in PBS for 30 min. After washing, cells were incubated overnight at 4 o C with either primary antibody against 8-OHdG, 5-methylcytosine (5 g/ml), or an IgG control. Cells were then washed three times and incubated with a secondary antibody conjugated to Fluorescein isothiocyanate (FITC) for 2 h. Samples were counterstained with 4 ,6-diamidino-2-phenylindole (DAPI) and washed three times with PBS. Mounting medium was applied and the cover slips inverted onto glass slides. Visualization was performed using a Nikon AZ100 fluorescence microscope (Nikon, Melville, NY) with excitation and emission filters of 488 and 520 nm, respectively, for 8-OHdG and 5-methylcytosine, and 350 and 486 nm, respectively, for DAPI.
Methylation-specific PCR. Cells were seeded in 6-well plates (32,000 cells/ml) and grown for 24 h. Cells were then exposed to low doses of KBrO 3 (0-10 ppm) for up to 18 days. Cells were passaged every 3 days and at least 1/2 of the cells were preserved for analysis, whereas the other 1/2 were sub-cultured. Cell aliquots were passaged and treated again for 3 days. At each passage, 1/2 of the cells were homogenized and genomic DNA extracted using a DNeasy tissue kit (Qiagen, Valencia, CA) following the manufacturer's protocol. Bisulfite conversion of DNA was performed using the CpGenome DNA Modification kit (Chemicon International, Billerica, MA) following the manufacturer's protocol. Converted DNA was amplified via PCR with primers specific for a CpG-rich region of p21. The methylated and un-methylated primers amplified coding region residues 9577-9903 and 9577-9906, respectively, of the rat p21 gene. The products were confirmed by electrophoresis on a 2% agarose gel. The primers used are as follows:
Methylated Rat p21
sense: 5 -TGTAATTAGTTATAGGTATTATGTTCGA-3 anti-sense: 5 -ACCCCTACAACAAAACCGAA-3
Un-methylated Rat p21
sense: 5 -TGTATTAGTTATAGGTATTATGTTTGA-3 anti-sense: 5 -CTAACCCCTACAACAAAACCAAA-3
Statistical analysis. Cells isolated from a distinct passage represented one experiment (n = 1). Unless otherwise indicated, data are represented as the mean ± SEM of at least three separate experiments (n = 3). An analysis of variance followed by Tukey's post hoc test was performed for each data set using GraphPad Prism software with p Ͻ 0.05 being considered indicative of a statistically significant difference.
RESULTS
Effect of KBrO 3 on Global DNA Methylation
Global DNA methylation can be detected using several methods including immunohistochemistry, enzyme-linked immunosorbent assays, liquid chromatography tandem mass spectrometry, and so on (Vassar et al., 2009) . Immunofluorescence approaches use a 5-methylcytosine antibody in tandem with a nuclear counter stain such as DAPI. We used this technique to demonstrate that neither 100 ppm nor 200 ppm KBrO 3 increased 5-methylcytosine staining in NRK cells after 3 days of treatment ( Fig. 1) , compared with controls. This suggests that these doses of KBrO 3 may not alter global DNA methylation.
Effect of 5-Aza and TSA on KBrO 3 -Induced Cytotoxicity
Our lab previously reported that KBrO 3 treatment alters both mRNA and protein expression in vitro and in vivo (Kolisetty et al., 2013b; Zhang et al., 2010) . It is unknown if these alterations in expression occur via epigenetic mechanisms, or if epigenetic regulation is involved in KBrO 3 toxicity. 5-Aza and TSA are DNMT and HDAC inhibitors, respectively (Christman, 2002; Yoshida et al., 1995) . DNA methylation and histone deacetylation are modes of epigenetic regulation that generally result in a decrease in gene transcription and expression. Inhibition of these catalyzing enzymes, therefore, inhibits this silencing of expression.
To study the role of epigenetic regulation on KBrO 3 -induced cytotoxicity, we treated NRK cells with various concentrations of TSA or 5-Aza, in the presence and absence of KBrO 3 . The concentrations of KBrO 3 used were based on our previous in vitro and in vivo studies (Kolisetty et al., 2013a (Kolisetty et al., , 2013b Zhang et al., 2010) . The concentrations of 5-Aza and TSA used were based on literature studies investigating DNMT and HDAC inhibitory activity (Creusot et al., 1982; Vigushin et al., 2001) , as well as our own preliminary toxicity studies (data not shown). Treatment of cells with KBrO 3 alone induced a slight, but significant, decrease in MTT staining compared with controls (Fig. 2) . Treatment of cells with 5-Aza also resulted in a slight decrease in MTT staining compared with controls ( Fig. 2A) . In contrast, TSA treatment had a greater effect on MTT staining (Fig. 2B) . Treatment of cells with 5-Aza and KBrO 3 resulted in greater decreases FIG. 4 . Effect of low doses of KBrO3 on NRK cell morphology and number. NRK cells were exposed to 0-50 ppm KBrO3 for 3 days and then passaged and retreated for an additional 3 days for seven total passages. Cell morphology (A-F) and cell number (G) were assessed after each passage. Data in (A-G) are representative of at least five independent experiments and are cells at passage 7. Data in (G) are representative of at least five separate passages (n = 5).
in MTT staining compared with cells exposed to KBrO 3 alone. Similar results were seen with TSA ( Fig. 2B ) and in HEK293 cells (Supplementary fig. 1 ). These data were confirmed using cell and nuclear morphology (Figs. 2C-F) .
Effect of 5-Aza and TSA on KBrO 3 -Induced Protein Expression
We next assessed the effect of 5-Aza and TSA on the expression of proteins we previously demonstrated to be altered by KBrO 3 , including p38, p53, H2AX and p21 (Zhang et al., 2010) . 5-Aza and TSA alone had a minimal effect on p-p38 expression, compared with control cells. In contrast, 5-Aza treatment induced a marked increase in p-p53 and p21 expression. Interestingly, TSA alone had a minimal effect on p-p53 levels, but still slightly increased p21 expression.
Treatment of NRK cells with 20-M 5-Aza and 100 ppm KBrO 3 for 3 days did not significantly alter the expression of p-p38 compared with cells treated with KBrO 3 or the inhibitor alone (Fig.  3) . Treatment with 5-Aza and KBrO 3 did not appear to increase p-p53 expression, but did decrease p21 and p-H2AX expression compared with KBrO 3 alone. Similar to 5-Aza, treatment with TSA did not appear to alter p-p38 expression, but did lower pp53, p21 and p-H2AX expression compared with KBrO 3 alone. Similar results were seen in HEK293 cells, with the exception that changes in p21 and p-H2AX were not as large (Supplementary fig. 2 ).
Effect of Low Doses of KBrO 3 on Cell Morphology and Cell Count
A limitation of the above studies is that the doses of KBrO 3 used were much higher than those encountered within the environment. Therefore, we studied the effect of low doses of KBrO 3 on cell death and protein expression after sub-chronic exposure. These doses include 10 ppb (or 0.01 ppm), which is the recommended maximum containment limit (MCL) for BrO 3 − suggested by the United States Environmental Protection Agency (EPA, 2012). We could not study the sub-chronic effect of KBrO 3 in combination with 5-Aza and TSA due to the toxicity seen with the inhibitors after long-term exposure (data not shown). Treatment of NRK cells with 50 ppm KBrO 3 induced significant alterations in cell morphology starting after 9 days of treatment (three passages); on the other hand, concentrations of KBrO 3 lower than 50 ppm did not significantly alter cell morphology (Figs. 4A-F) . Similar results were seen in HEK293 cells (Supplementary fig. 3 ). KBrO 3 treatment started to decrease NRK cell number after exposure to 10 ppm for 15 days (five passages, Fig.  4G ). Treatment of NRK cells with doses of KBrO 3 lower than 50 ppm did not decrease MTT staining at any dose studied (data not shown). These doses of KBrO 3 also did not result in detectable increases in 8-OHdG staining, a marker of KBrO 3 -induced DNA damage (Fig. 5) . Similarly, we did not detect any changes in nuclear morphology that would indicate the occurrence of apoptosis (i.e., nuclear fragmentation, chromatin condensation; Fig.  5 ).
FIG. 5.
Effect of low doses of KBrO3 on NRK cell nuclear morphology and 8-OHdG formation. NRK cells were treated with 100 ppb or 10 ppm KBrO3 for 9 days prior to analysis of nuclear morphology and 8-OHdG staining using fluorescence microscopy. DAPI staining is shown in the right column 8-OHdG staining is shown in left column. Data are representative of at least three independent experiments (n = 3).
Effect of Low Doses of KBrO 3 on the Expression of Stress Response Proteins
Treatment of cells with low doses of KBrO 3 for 3 days (one passage) caused a general increase in the expression of p-p38 and appeared to increase p21 expression compared with control at all doses tested (Fig. 6A) . KBrO 3 treatment for 6 days (two passages) increased the expression p-H2AX at doses as low as 10 ppb (Fig. 6B) . Expression of p-p38 and that of p-p53 were also increased after 6 days of exposure to the lowest concentration of KBrO 3 tested (Fig. 6B) ; however, treatment of cells with KBrO 3 for 9 days (three passages) resulted in a return of p-p38 and p-p53 expression to control levels (Fig. 6C) , and this trend was maintained after 18 days of treatment (data not shown).
As mentioned above, treatment of NRK cells for 3 days with KBrO 3 altered p21 protein expression at doses as low as 0.01 ppm (10 ppb; Fig. 6A ). Unlike p-p38 and p-p53, p21 protein expression continued to differ from control cells after 6 and 9 days of treatment (Figs. 6B and C) . Interestingly, KBrO 3 treatment induced a biphasic response in p21 expression after 6 and 9 days, with lower concentrations increasing protein expression, but higher concentrations (10 ppm) decreasing expression. To our knowledge, these are the lowest concentrations of KBrO 3 demonstrated to alter protein expression in any model.
Effect of KBrO 3 on DNA Methylation of the p21
Gene DNA methylation plays a crucial role in carcinogenesis through methylating cytosine residues of various tumor suppressor genes, silencing their transcription (Yu and Wang, 2008) . With this in mind, we tested the hypothesis that KBrO 3 -induced changes in p21 protein expression correlate to changes in methylation of cytosine residues of p21. Treatment of NRK cells with 0.01-1 ppm KBrO 3 increased the level of un-methylated p21 after 18 days of treatment, whereas treatment of cells with 10 ppm KBrO 3 did not induce alterations in methylated or unmethylated p21 expression compared with control (Fig. 6D) . In contrast, treatment with the same concentration of KBrO 3 resulted in slight decreases in methylated p21 at 0.01 ppm. These data are in agreement with the protein expression data presented in Fig. 6C .
DISCUSSION
This study showed that inhibitors of DNMT and HDAC altered cell death induced by BrO 3 − , a common water DBP and possible human carcinogen. As mentioned above, DNMT and HDAC are important epigenetic regulators, and mediate the transcription of numerous genes (Unoki et al., 2009) . Thus, these data suggest that KBrO 3 -induced renal cell death may be mediated, in part, by epigenetic mechanisms. This conclusion is supported by data demonstrating that DNMT and HDAC inhibitors also alter the effect of KBrO 3 on the expression of several stress-related proteins. Further, KBrO 3 induced alterations in the methylation of p21 DNA. To our knowledge, this is one of the first reports demonstrating that the toxicity of any DBP is altered by DNMT or HDAC inhibitors. However, this is not the first report to demonstrate that DBPs can alter DNA methylation. In fact, Tao et al. (2005) showed that DNA hypomethylation was induced in mouse and rat kidneys after treatment with several different DBPs, such as dibromoacetic acid, dichloroacetic acid and tricholoracetic acid (Ge et al., 2001; Tao et al., 2005) . None of these studies, however, included KBrO 3 . It should also be noted that the above studies used high doses of DPBs (500 mg/kg), which may not be environmentally relevant.
Although no studies exist assessing if DNMT or HDAC inhibitors mediate KBrO 3 -induced cell death, a few do exist testing the effect of TSA or 5-Aza on cisplatin-induced nephrotoxicity (Arany et al., 2008; Dong et al., 2010; Sakao et al., 2011; Tikoo et al., 2009) . In contrast to our data with KBrO 3 , these studies suggest that these inhibitors were protective against cisplatin-induced nephrotoxicity (Dong et al., 2010; Tikoo et al., 2009) . Thus, the effect of DMNT or HDAC inhibitors on chemical-induced nephrotoxicity may be chemical-specific.
A limitation of many studies assessing the mechanisms of DBP toxicity, including our own, is that the concentrations of DPBs used are often high compared with the environmental levels. For example, our previous studies used concentrations of KBrO 3 in the range of 15-400 ppm (Kolisetty et al., 2013a; Zhang et al., 2010) . However, KBrO 3 levels in most drinking water ranges from 10 to 100 ppb. We addressed this limitation in this study by using low-dose and sub-chronic treatments. Similar to data seen with high-dose acute exposures, exposure of NRK cells to KBrO 3 at concentrations ranging from 0.01 to 10 ppm altered the expression of p-H2AX, p-p53, p-p38 and p21 after 3, 6 and 9 days. These data suggest that the mode of action of low doses of KBrO 3 may be similar to that seen at higher doses if allowed sufficient treatment time. An important aspect of these findings is that increases in 8-OHdG staining were not detected at these doses, nor were changes in nuclear morphology, suggesting that KBrO 3 can induce alterations in cell signaling that occur in the absence of wide-spread DNA damage.
This study also investigated the effect of KBrO 3 on the epigenetic status of p21. p21 is a cell cycle regulator whose protein and mRNA expression have been shown by us to be altered both in vitro and in vivo after KBrO 3 treatment (Kolisetty et al., 2013a; Zhang et al., 2010) . Our data show that KBrO 3 alters the level of p21 DNA methylation at doses as low as 0.01 ppm and after
FIG. 6.
Effect of low doses of KBrO3 on the expression and methylation of stress response and cell-cycle-related proteins in NRK cells. Cells were exposed to 0-50 ppm KBrO3 for 3 days (A), then cells were sub-cultured and retreated for an additional 3 days (B), and sub-cultured and retreated again (C), prior to immunoblot analysis. p38 is shown as a loading control. After the final treatment (day 18) total DNA was extracted, subjected to bisulfite conversion followed by methylation-specific PCR for p21, and analyzed on 2% agarose gels stained with ethidium bromide and visualized under UV light (D). Data are representative of at least three independent experiments (n = 3).
only 6 days of exposure and that these alterations persist after 9 days of exposure. The inability of KBrO 3 , even at high doses, to increase global DNA methylation compared with control cells suggests that KBrO 3 exposure may not alter the overall activity of DNMTs and that this effect is gene-specific.
No studies could be found demonstrating that any DPB, let alone KBrO 3 , can alter p21 gene methylation. Our data show a biphasic response of p21 methylation to KBrO 3 exposure. Low doses (0.01-1 ppm) of KBrO 3 increased the level of unmethylated p21 in kidney cells, indicating hypomethylation; however, exposure to 10 ppm KBrO 3 decreased the expression of un-methylated p21, indicating hypermethylation. The shift in favor of un-methylated p21 seen with lower doses correlates to the increase in p21 protein expression observed under similar conditions. As previously mentioned, p21 is a tumor suppressor and the increases in p21 expression after low-dose KBrO 3 treatment may be a protective response, as p21 is known to protect against nephrotoxicity induced by several compounds (Abukhdeir and Park, 2008; Jiang and Dong, 2008; Megyesi et al., 2001; Nowak et al., 2003; Price et al., 2009) . This hypothesis is supported by our data showing that the increase in cell death induced by 5-Aza and TSA after acute exposure to KBrO 3 correlates to decreases in p21 expression. It should also be noted that increases in cell death correlated to increases in p53 expression as well.
The biphasic response in p21 expression observed after subchronic treatment to low doses of KBrO 3 is puzzling. The decrease in un-methylated p21 seen with 10 ppm could be indicative of an increase in DNA damage that was not detectable using the methods employed herein, and may represent a threshold for cell death, which was observed at 50 ppm. These doses are nearing the range of KBrO 3 shown to induce carcinogenesis in vivo after long-term treatments Kurokawa et al., 1990; Wolf et al., 1998) . Interestingly, studies suggest that hypermethylation of the p21 gene is associated with increased risk of developing certain cancers, as well as with decreased cancer survival rate (Askari et al., 2013; Roman-Gomez et al., 2002) . Thus, the decrease in un-methylated p21 and p21 protein expression at 10 ppm may represent initial mechanisms of transformation in these cells. Future studies are needed to address this hypothesis. The ability of KBrO 3 to alter p21 methylation in vivo also needs to be assessed.
It is important to note that the alterations in gene methylation and protein expression induced by KBrO 3 doses near the MCL (0.01 ppm or 10 ppb) may not be "toxic." Rather, these changes may be more "adaptive" in nature. This assertion is supported by the fact that we detected no increases in cell death using a variety of assays (cell morphology, nuclear morphology, 8-OHdG staining, etc.). Additionally, our previous studies showed that 10 ppm KBrO 3 did not increase ROS formation, annexin, or PI staining, or decrease ATP levels after 72 h (Zhang et al., 2010) .
Even though the doses of KBrO 3 used here are among the lowest ever shown to induce altered cell signaling or molecular changes, it is still possible that renal cells in vivo might not be exposed to concentrations of KBrO 3 as high as 10 ppb. This hypothesis is supported by our recent kinetic analysis of KBrO 3 in blood and urine of rats after both acute and sub-chronic exposures, which suggested KBrO 3 levels below 1 mg/kg would al-most be completely converted to bromide (Br − ) after oral ingestion (Bull et al., 2012) . The concentrations of TSA and 5-Aza used for our study have been previously shown to inhibit HDAC and DNMT activity, respectively (Creusot et al., 1982; Vigushin et al., 2001) ; however, both TSA and 5-Aza can have non-specific effects, especially at high concentrations. For example, TSA can alter the acetylation of non-histone proteins, particularly transcription factors, thereby affecting their function (Adcock, 2007) . Further, 5-Aza can be incorporated into RNA, in addition to DNA, causing disruption of nucleic acid and protein metabolism and leading to apoptosis (Aimiuwu et al., 2012; Kiziltepe et al., 2007; Kuykendall, 2005) . Before determining the specificity of TSA and 5-Aza for epigenetic mediators, we first wanted to ensure that these inhibitors altered the toxicity of BrO 3 − . The importance of the individual HDACs and DNMTs inhibited and the specificity of the inhibitors will be addressed in future studies using molecular approaches. In conclusion, data reported in this study demonstrate that treatment of renal cells with inhibitors of enzymes important for epigenetic regulation alters KBrO 3 -induced renal cell death. These data also demonstrate that KBrO 3 treatment itself alters DNA methylation of p21 and that such alterations are manifested phenotypically, based on changes in protein expression. These findings yield novel insights into the mechanism of KBrO 3 -induced cytotoxicity. The data also beg the question if other DBPs also induce epigenetic changes, what other genes may be altered, and if such changes can be detected in vivo. Finally, it is known that epigenetic regulation of gene expression is species-specific, so studies in human models of renal cell death are still needed.
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